Pathology algorithms help in the classification of cancer into subtypes, each of which may respond differently to treatment. For instance, in breast cancer, algorithms can differentiate between hormone receptor-positive, HER2-positive, and triple-negative subtypes. This classification is critical in selecting targeted therapies, like hormone therapy for receptor-positive cancers or HER2 inhibitors for HER2-positive cancers.
